Finbar Larkin is VP at Jazz Pharmaceuticals plc (JAZZ). They have made 11 open-market trades across 1 company since 2020, most recently 2023-03-07.
CIK 0001793243
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| JAZZ | 23,854 | $5.6M |
Shares reported on the most recent Form 4, priced at the 2023-03-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| JAZZ | SELL | 2023-03-06 | 2023-03-07 | $142.73 | $783K | -2.8% | +5.8% | -6.7% |
| JAZZ | SELL | 2022-11-14 | 2022-11-16 | $149.33 | $29K | +9.7% | +11.2% | +6.2% |
| JAZZ | SELL | 2022-09-07 | 2022-09-09 | $150.00 | $9K | -12.9% | -12.8% | -1.9% |
| JAZZ | SELL | 2022-05-09 | 2022-05-11 | $148.94 | $520K | +1.9% | +3.3% | +9.7% |
| JAZZ | SELL | 2021-11-12 | 2021-11-16 | $135.79 | $27K | -10.3% | -8.8% | +4.2% |
| JAZZ | SELL | 2021-09-08 | 2021-09-10 | $134.51 | $8K | -4.5% | +0.8% | -9.3% |
| JAZZ | SELL | 2021-03-08 | 2021-03-10 | $161.60 | $488K | +4.0% | -1.6% | +9.1% |
| JAZZ | SELL | 2020-11-06 | 2020-11-10 | $151.93 | $30K | -5.4% | -3.0% | +9.8% |
| JAZZ | SELL | 2020-09-09 | 2020-09-10 | $138.53 | $9K | -0.5% | +10.6% | +4.4% |
| JAZZ | SELL | 2020-03-06 | 2020-03-10 | $112.96 | $172K | -12.7% | -0.4% | +1.0% |
| JAZZ | SELL | 2020-03-03 | 2020-03-05 | $119.75 | $33K | -11.2% | -11.2% | -0.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.